Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Octa, Stroke, Subarachnoid Hemorrhage, Intracerebral Hemorrhage
Interventions: OCTA; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Celiac Disease
Interventions: Gluten containing snack bar; Dietary Supplement
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Pasadena, California • Chicago, Illinois • Rochester, Minnesota

Conditions: Hypertension
Interventions: Stool Sample and Blood Sample; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 292 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Opioid Use, Shoulder Osteoarthritis, Avascular Necrosis, Rotator Cuff Tear, Arthritis;Inflammatory
Interventions: Gabapentin, Celecoxib, toradol, acetaminophen, regional block, propofol, IV lidocaine, rocuronium, vecuronium, sevoflurane, desflurane; Drug
Lead sponsor: OrthoCarolina Research Institute, Inc.; Other
Eligibility: 50 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Traumatic Brain Injury
Interventions: SENSE device; Device
Lead sponsor: Sense Diagnostics, LLC; Industry
Eligibility: 22 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Gainesville, Florida • Cincinnati, Ohio • Pittsburgh, Pennsylvania + 3 more

Conditions: Skin Wound, Soft Tissue Injuries
Interventions: NP-PWD, Wound Vac; Device
Lead sponsor: The Metis Foundation; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hepatic Insufficiency, Neoplasms
Interventions: Onureg; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 4
States / cities: Iowa City, Iowa • Detroit, Michigan • Cleveland, Ohio + 1 more

Conditions: Type 2 Diabetes, High Blood Pressure, Arthritis, Obesity
Interventions: Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High; Drug
Lead sponsor: ARKAY Therapeutics; Industry
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Albany, New York

Conditions: Hepatic Impairment, Moderate Impaired Hepatic Function
Interventions: Quizartinib; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Miami, Florida • Orlando, Florida

Conditions: Bacterial Infection, Anti-infective Agents, Breast Implantation
Interventions: Cefadroxil discontinued early, Cefadroxil until drain removal; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Migraine
Interventions: Magnesium, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Oak Lawn, Illinois

Conditions: Cesarean Section Complications, Wound Breakdown, Wound Infection, Satisfaction, Surgical Wound Infection
Interventions: ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG), Standard Wound Care; Combination Product · Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 154 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Retraction of Colostomy
Interventions: IV morphine sulfate or Sponsor-approved equivalent, EXPAREL; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 3
States / cities: Tucson, Arizona • Orlando, Florida • Tampa, Florida

Conditions: Pain
Interventions: Ketamine 0.15mg/kg, Ketamine 0.3mg/kg, Placebo; Drug · Other
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Cancer
Interventions: Vismodegib; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 5
States / cities: Chicago, Illinois • Baltimore, Maryland • Detroit, Michigan + 2 more

Conditions: Amyotrophic Lateral Sclerosis (ALS), Neuromuscular Diseases
Interventions: Acute Intermittent Hypoxia, Sham Acute Intermittent Hypoxia; Other
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Inflammatory Bowel Diseases, Colo-rectal Cancer
Interventions: no intervention will be given to patients.; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 99 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Diabetes in Pregnancy, Diabetes, Gestational, Infant, Newborn, Diseases, Perinatal Disorders of Growth and Development
Interventions: Video Electroencephalogram (EEG), Point-of Care Blood Sugar Testing, Medical Record Data Extraction, Maternal Questionnaire; Other
Lead sponsor: University of Rochester; Other
Eligibility: 24 Hours to 120 Hours
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases
Interventions: NHS7108, Zenpep®; Drug
Lead sponsor: Aimmune Nestlé Health Science US R&D, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 14
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • Los Angeles, California + 10 more

Conditions: Bowel Obstruction
Interventions: morphine sulfate, bupivacaine liposome extended-release injectable suspension; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pregnancy in Adolescence, Sexually Transmitted Diseases
Interventions: Wrap It Up (WIU); Behavioral
Lead sponsor: ETR Associates; Other
Eligibility: 16 Years to 19 Years
Enrollment: 1,120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Scotts Valley, California

Conditions: Eating Disorders
Interventions: Not listed
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Ischemic Stroke
Interventions: Privigen, Normal Saline; Biological · Other
Lead sponsor: Inova Health Care Services; Other
Eligibility: 45 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Open Abdomen After Damage Control Laparotomy
Interventions: Primary Fascial Closure, wound vac dressing application; Procedure · Device
Lead sponsor: San Antonio Military Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Search by objective public record fields.

Optical Coherence Tomography Angiography in Neurological Disease

Tissue Destruction and Healing in Celiac Disease

The Role of Gut Microbiota in Hypertension

Opioid-Free Shoulder Arthroplasty

A Study to Evaluate the SENSE Device's Ability to Detect TBI

A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic Impairment

Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery

A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504

Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department

A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Collection of Gastrointestinal Malignant and Non-malignant Human Samples

Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)

A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301

Wrap It Up Rigorous Evaluation

Determining the Response to Sipping Beverages Without Swallowing in People With Eating Disorders

IVIG in Acute Ischemic Stroke: A Pilot Study

Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure